TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Anti-Infective Agents Market – By Type
1.3.2 North America Anti-Infective Agents Market – By Range
1.3.3 North America Anti-Infective Agents Market – By Route of Administration
1.3.4 North America Anti-Infective Agents Market – By Indication
1.3.5 North America Anti-Infective Agents Market – By Distribution Channel
1.3.6 North America Anti-Infective Agents Market – By Country
2. North America Anti-Infective Agents Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Anti-infective Agents Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Anti-Infectives Agents Market – Key Market Dynamics
5.1 Key Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Surging Government Support for Research Activities and Clinical Trials
5.2 Market Restraints
5.2.1 Emergence of Anti-infective Drugs Resistance and Their Side Effects
5.3 Market Opportunities
5.3.1 Development of New Anti-infective Agents
5.4 Future Trends
5.4.1 Rising Investments in R&D Activities in Pharmaceutical Sector
5.5 Impact Analysis
6. Anti-Infectives Agents Market – North America Analysis
6.1 North America Anti-Infectives Agents Market Revenue Forecast and Analysis
7. North America Anti-Infectives Agents Market Analysis and Forecast to 2028 – Type
7.1 Overview
7.2 North America Anti-infectives Agents Market, by Type, 2022 & 2028 (%)
7.3 Anti-Viral
7.3.1 Overview
7.3.2 Anti-Viral Market Revenue and Forecast to 2028 (US$ Million)
7.4 Anti-Bacterial
7.4.1 Overview
7.4.2 Anti-Bacterial Market Revenue and Forecast to 2028 (US$ Million)
7.5 Anti-Fungal
7.5.1 Overview
7.5.2 Anti-Fungal Market Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
8. North America Anti-Infectives Agents Market Analysis and Forecast to 2028 – Range
8.1 Overview
8.2 North America Anti-Infectives Agents Market, by Range, 2022 & 2028 (%)
8.3 Narrow Spectrum
8.3.1 Overview
8.3.2 Narrow Spectrum Market Revenue and Forecast to 2028 (US$ Million)
8.4 Broad Spectrum
8.4.1 Overview
8.4.2 Broad Spectrum Market Revenue and Forecast to 2028 (US$ Million)
9. North America Anti-Infectives Agents Market Analysis and Forecast to 2028 – Route of Administration
9.1 Overview
9.2 North America Anti-Infectives Agents Market, by Route of Administration, 2022 & 2028 (%)
9.3 IV
9.3.1 Overview
9.3.2 IV Market Revenue and Forecast to 2028 (US$ Million)
9.4 Oral
9.4.1 Overview
9.4.2 Oral Market Revenue and Forecast to 2028 (US$ Million)
9.5 Topical
9.5.1 Overview
9.5.2 Topical Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
10. North America Anti-Infectives Agents Market Analysis and Forecast to 2028 – Indication
10.1 Overview
10.2 North America Anti-Infectives Agents Market, by Indication, 2022 & 2028 (%)
10.3 HIV
10.3.1 Overview
10.3.2 HIV Market Revenue and Forecast to 2028 (US$ Million)
10.4 Tuberculosis
10.4.1 Overview
10.4.2 Tuberculosis Market Revenue and Forecast to 2028 (US$ Million)
10.5 Respiratory Infection
10.5.1 Overview
10.5.2 Respiratory Infection Market Revenue and Forecast to 2028 (US$ Million)
10.6 Pneumonia
10.6.1 Overview
10.6.2 Pneumonia Market Revenue and Forecast to 2028 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)
11. North America Anti-Infectives Agents Market Analysis and Forecast to 2028 – Distribution Channel
11.1 Overview
11.2 North America Anti-Infectives Agents Market, by Distribution Channel, 2022 & 2028 (%)
11.3 Hospital Pharmacies
11.3.1 Overview
11.3.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.4 Retail Pharmacies
11.4.1 Overview
11.4.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.5 Specialty Pharmacies
11.5.1 Overview
11.5.2 Specialty Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.6 E-Commerce
11.6.1 Overview
11.6.2 E-Commerce Market Revenue and Forecast to 2028 (US$ Million)
11.7 Others
11.7.1 Overview
11.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)
12. North America Anti-Infectives Agents Market Analysis and Forecasts To 2028 – Country Analysis
12.1 Overview
12.1.1 North America: Anti-Infective Agents Market, by Country, 2022 & 2028 (%)
12.1.1.1 US: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.1.1.1.1 Overview
12.1.1.1.2 US: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.1.1.1.3 US: Anti-Infective Agents Market, by Type, 2019–2028 (US$ Million)
12.1.1.1.4 US: Anti-Infective Agents Market, by Range, 2019–2028 (US$ Million)
12.1.1.1.5 US: Anti-Infective Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.1.1.6 US: Anti-Infective Agents Market, by Indications, 2019–2028 (US$ Million)
12.1.1.1.7 US: Anti-Infective Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
12.1.1.2 Canada: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.1.1.2.1 Overview
12.1.1.2.2 Canada: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.1.1.2.3 Canada: Anti-Infective Agents Market, by Type, 2019–2028 (US$ Million)
12.1.1.2.4 Canada: Anti-Infective Agents Market, by Range, 2019–2028 (US$ Million)
12.1.1.2.5 Canada: Anti-Infective Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.1.2.6 Canada: Anti-Infective Agents Market, by Indications, 2019–2028 (US$ Million)
12.1.1.2.7 Canada: Anti-Infective Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
12.1.1.3 Mexico: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.1.1.3.1 Overview
12.1.1.3.2 Mexico: Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)
12.1.1.3.3 Mexico: Anti-Infective Agents Market, by Type, 2019–2028 (US$ Million)
12.1.1.3.4 Mexico: Anti-Infective Agents Market, by Range, 2019–2028 (US$ Million)
12.1.1.3.5 Mexico: Anti-Infective Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.1.3.6 Mexico: Anti-Infective Agents Market, by Indications, 2019–2028 (US$ Million)
12.1.1.3.7 Mexico: Anti-Infective Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
13. Anti-infectives Agents Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies In The Anti-infective agents Market, 2018-2022
13.3 Organic Developments
13.3.1 Overview
13.3.2 Organic Growth Strategies In The Anti-infective agents Market, 2018-2022
13.4 Inorganic Developments
13.4.1 Overview
13.4.2 Inorganic Growth Strategies In The Anti-infective agents Market, 2018-2022
14. Anti-Infectives Agents Market- Company Profiles
14.1 Abbott
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Allergan Plc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Astellas Pharma Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Merck & Co., Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bayer AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Bristol-Myers Squibb Company
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Boehringer Ingelheim International GmbH
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 F. HOFFMANN-LA ROCHE LTD.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Gilead Sciences, Inc.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 GlaxoSmithKline plc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Novartis AG
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms